C. Demangel, T. P. Stinear, and S. T. Cole, Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans, Nat. Rev. Microbiol, vol.7, pp.50-60, 2009.

M. Wansbrough-jones and R. Phillips, Buruli ulcer: emerging from obscurity, Lancet, vol.367, pp.1849-1858, 2006.

S. Etuaful, B. Carbonnelle, J. Grosset, S. Lucas, C. Horsfield et al., Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans, Antimicrob. Agents Chemother, vol.49, pp.3182-3186, 2005.

K. Huygen, O. Adjei, D. Affolabi, G. Bretzel, C. Demangel et al., Buruli ulcer disease: prospects for a vaccine, Med. Microbiol. Immunol. (Berl.), vol.198, pp.69-77, 2009.

L. Guenin-macé, R. Siméone, and C. Demangel, Lipids of pathogenic Mycobacteria: contributions to virulence and host immune suppression, Transbound Emerg Dis, vol.56, pp.255-268, 2009.

K. M. George, D. Chatterjee, G. Gunawardana, D. Welty, J. Hayman et al., Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence, vol.283, pp.854-857, 1999.

J. Guarner, J. Bartlett, E. A. Whitney, P. L. Raghunathan, Y. Stienstra et al., Histopathologic features of Mycobacterium ulcerans infection, Emerg. Infect. Dis, vol.9, pp.651-656, 2003.

K. M. George, L. Pascopella, D. M. Welty, and P. L. Small, A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells, Infect. Immun, vol.68, pp.877-883, 2000.

H. Hong, C. Demangel, S. J. Pidot, P. F. Leadlay, and T. Stinear, Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria, Nat. Prod. Rep, vol.25, pp.447-454, 2008.

E. Coutanceau, L. Marsollier, R. Brosch, E. Perret, P. Goossens et al., Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin, Cell. Microbiol, vol.7, pp.1187-1196, 2005.

A. A. Pahlevan, D. J. Wright, C. Andrews, K. M. George, P. L. Small et al., The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-k B function, J. Immunol, vol.163, pp.3928-3935, 1999.

E. Torrado, S. Adusumilli, A. G. Fraga, P. L. Small, A. G. Castro et al., Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection, Infect. Immun, vol.75, pp.3979-3988, 2007.

R. E. Simmonds, F. V. Lali, T. Smallie, P. L. Small, and B. M. Foxwell, Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism, J. Immunol, vol.182, pp.2194-2202, 2009.

E. Coutanceau, J. Decalf, A. Martino, A. Babon, N. Winter et al., Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone, J. Exp. Med, vol.204, pp.1395-1403, 2007.
URL : https://hal.archives-ouvertes.fr/pasteur-01402321

R. Phillips, F. S. Sarfo, L. Guenin-macé, J. Decalf, M. Wansbrough-jones et al., Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease, J. Infect. Dis, vol.200, pp.1675-1684, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-01402286

T. M. Gooding, A. S. Kemp, R. M. Robins-browne, M. Smith, and P. D. Johnson, Acquired T-helper 1 lymphocyte anergy following infection with Mycobacterium ulcerans, Clin. Infect. Dis, vol.36, pp.1076-1077, 2003.

R. Phillips, C. Horsfield, S. Kuijper, S. F. Sarfo, J. Obeng-baah et al., Cytokine response to antigen stimulation of whole blood from patients with Mycobacterium ulcerans disease compared to that from patients with tuberculosis, Clin. Vaccine Immunol, vol.13, pp.253-257, 2006.

G. Prévot, E. Bourreau, H. Pascalis, R. Pradinaud, A. Tanghe et al., Differential production of systemic and intralesional g interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease, Infect. Immun, vol.72, pp.958-965, 2004.

B. D. Westenbrink, Y. Stienstra, M. G. Huitema, W. A. Thompson, E. O. Klutse et al., Cytokine responses to stimulation of whole blood from patients with Buruli ulcer disease in Ghana, Clin. Diagn. Lab. Immunol, vol.12, pp.125-129, 2005.

D. Yeboah-manu, E. Peduzzi, E. Mensah-quainoo, A. Asante-poku, D. Ofori-adjei et al., Systemic suppression of interferon-g responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans, J. Leukoc. Biol, vol.79, pp.1150-1156, 2006.

D. Schütte, A. Um-boock, E. Mensah-quainoo, P. Itin, P. Schmid et al., Development of highly organized lymphoid structures in buruli ulcer lesions after treatment with rifampicin and streptomycin, PLoS Negl. Trop. Dis, vol.1, p.2, 2007.

D. Schütte and G. Pluschke, Immunosuppression and treatment-associated inflammatory response in patients with Mycobacterium ulcerans infection (Buruli ulcer), Expert Opin. Biol. Ther, vol.9, pp.187-200, 2009.

F. S. Sarfo, R. O. Phillips, E. Ampadu, F. Sarpong, E. Adentwe et al., Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humans, Clin. Vaccine Immunol, vol.16, pp.61-65, 2009.

H. Hong, E. Coutanceau, M. Leclerc, L. Caleechurn, P. F. Leadlay et al., Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs, PLoS Negl. Trop. Dis, vol.2, p.325, 2008.

E. Serfling, A. Avots, and M. Neumann, The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation, Biochim. Biophys. Acta, vol.1263, pp.181-200, 1995.

L. Beretta, A. C. Gingras, Y. V. Svitkin, M. N. Hall, and N. Sonenberg, Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation, EMBO J, vol.15, pp.658-664, 1996.

J. Chung, C. J. Kuo, G. R. Crabtree, and J. Blenis, Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases, Cell, vol.69, pp.1227-1236, 1992.

H. P. Harding, Y. Zhang, H. Zeng, I. Novoa, P. D. Lu et al., An integrated stress response regulates amino acid metabolism and resistance to oxidative stress, Mol. Cell, vol.11, pp.619-633, 2003.

O. Acuto, V. D. Bartolo, and F. Michel, Tailoring T-cell receptor signals by proximal negative feedback mechanisms, Nat. Rev. Immunol, vol.8, pp.699-712, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-00369557

U. D'oro, M. S. Vacchio, A. M. Weissman, and J. D. , Activation of the Lck tyrosine kinase targets cell surface T cell antigen receptors for lysosomal degradation, Immunity, vol.7, pp.619-628, 1997.

D. S. Snyder and P. L. Small, Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans, Microb. Pathog, vol.34, pp.91-101, 2003.

S. Feske, Calcium signalling in lymphocyte activation and disease, Nat. Rev. Immunol, vol.7, pp.690-702, 2007.

A. Faith, C. A. Akdis, M. Akdis, H. U. Simon, and K. Blaser, Defective TCR stimulation in anergized type 2 T helper cells correlates with abrogated p56 (lck) and ZAP-70 tyrosine kinase activities, J. Immunol, vol.159, pp.53-60, 1997.

T. F. Gajewski, D. Qian, P. Fields, and F. W. Fitch, Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways, Proc. Natl. Acad. Sci, vol.91, pp.38-42, 1994.

S. B. Gauld, R. J. Benschop, K. T. Merrell, and J. C. Cambier, Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling, Nat. Immunol, vol.6, pp.1160-1167, 2005.

C. A. Lowell, Src-family kinases: rheostats of immune cell signaling, Mol. Immunol, vol.41, pp.631-643, 2004.